Heart at Work Study

Sponsor
University of Pittsburgh (Other)
Overall Status
Completed
CT.gov ID
NCT04075279
Collaborator
(none)
19
1
9.2
2.1

Study Details

Study Description

Brief Summary

This is an observational study to examine the cardiovascular mechanisms of increased cardiovascular mortality in those with high activity occupations.

Detailed Description

The current proposal uses a repeated-measures, within-subject design to address our aims. Twenty male participants will report to the laboratory to provide informed consent, complete baseline assessments, and receive ambulatory monitors. Following this session, each participant will wear physical activity and ambulatory cardiovascular monitors for 7 days, including at least one non-work day and one work day. Characterization of work activity will use physical activity data from self-reported time at work (Specific Aim I). The 24-hour cardiovascular load (HR and BP) and nocturnal HRV will be compared across work and non-work days (Specific Aim II). Lastly, whether fitness level or job strain modify the difference in cardiovascular strain between work vs. non-work days will be evaluated (Specific Aim III).

Study Design

Study Type:
Observational
Actual Enrollment :
19 participants
Observational Model:
Case-Crossover
Time Perspective:
Cross-Sectional
Official Title:
Cardiovascular Mechanisms of the Occupational Physical Activity Health Paradox: 24-hour Physical Activity, Blood Pressure, and Heart Rate
Actual Study Start Date :
Oct 17, 2019
Actual Primary Completion Date :
Apr 20, 2020
Actual Study Completion Date :
Jul 24, 2020

Outcome Measures

Primary Outcome Measures

  1. 24-hour Heart Rate [24 hours]

    We will calculate the average heart rate over each 24 hour period throughout a one week monitoring period.

Secondary Outcome Measures

  1. 24-hour Ambulatory Systolic Blood Pressure [24 hours]

    We will calculate the average systolic blood pressure over a 24-hour period on two separate days (workdays versus non-workdays).

  2. Nocturnal Heart Rate Variability, RMSSD [approximately 8 hours (sleep time)]

    We will calculate the average heart rate variability during each night's sleep for a total of one week. The specific HRV variable presented is root mean square successive differences (RMSSD).

  3. Physical Activity Pattern. Steps Per Day [1 week]

    This physical activity metric of steps per day was calculated as average number of steps during each day type (work versus non-workdays) throughout one week

  4. Nocturnal Heart Rate Variability, SDNN [approximately 8 hours (sleep time)]

    We will calculate the average heart rate variability during each night's sleep for a total of one week. The specific HRV variable presented is standard deviation of the normal to normal RR intervals (SDNN).

  5. Nocturnal Heart Rate Variability, LF [approximately 8 hours (sleep time)]

    We will calculate the average heart rate variability during each night's sleep for a total of one week. The specific HRV variable presented is low frequency power (LF).

  6. Nocturnal Heart Rate Variability, HF [approximately 8 hours (sleep time)]

    We will calculate the average heart rate variability during each night's sleep for a total of one week. The specific HRV variable presented is high frequency power (HF).

  7. Physical Activity Pattern. MVPA [1 week]

    This physical activity metric of minutes of moderate to vigorous physical activity was calculated as average minutes during each day type (work versus non-workdays) throughout one week

  8. Physical Activity Pattern. LPA [1 week]

    This physical activity metric of minutes of light physical activity was calculated as average minutes during each day type (work versus non-workdays) throughout one week

  9. Physical Activity Pattern. Sedentary [1 week]

    This physical activity metric of minutes of sedentary time was calculated as average minutes during each day type (work versus non-workdays) throughout one week

  10. Physical Activity Pattern. Upright [1 week]

    This physical activity metric of minutes of upright time was calculated as average minutes during each day type (work versus non-workdays) throughout one week

  11. 24-hour Ambulatory Diastolic Blood Pressure [24 hours]

    We will calculate the average diastolic blood pressure over a 24-hour period on two separate days (workdays versus non-workdays).

Eligibility Criteria

Criteria

Ages Eligible for Study:
35 Years to 59 Years
Sexes Eligible for Study:
Male
Inclusion Criteria:
  • middle age (35-59 years)

  • male

  • self-report working full-time in the food service industry (≥30 hours/week)

  • self-report predominantly completing light intensity activity job responsibilities (≥75% work time walking, light movement, or standing)

Exclusion Criteria:
  • Resting blood pressure of ≥150 mmHg systolic and/or ≥95 mmHg diastolic

  • currently taking medications that are known to affect blood pressure or heart rate (e.g. Beta-blockers, ACE inhibitors, etc.)

  • greater than low risk to participate in physical activity as determined by PAR-Q (answer of yes to any of the 7 physical activity readiness questionnaire questions)

  • report working a second job in addition to their primary full-time job

  • report working overnight shifts (10pm-6am)

  • reported physical dysfunction (inability to walk 2 city blocks or climb 2 flights of stairs)

  • inability to complete the sub-maximal exercise test to completion (80% age-predicted heart rate maximum)

  • Currently being treated for a serious medical condition such as kidney disease, liver disease, cancer, or heart disease.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Physical Activity and Weight Management Research Laboratory Pittsburgh Pennsylvania United States 15261

Sponsors and Collaborators

  • University of Pittsburgh

Investigators

  • Principal Investigator: Tyler D Quinn, MS, Graduate Student

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Tyler Quinn, Principle Investigator, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT04075279
Other Study ID Numbers:
  • STUDY19050097
First Posted:
Aug 30, 2019
Last Update Posted:
May 3, 2021
Last Verified:
Apr 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Middle-aged Males in High Activity Occupations
Arm/Group Description All participants were enrolled into a single arm and all comparisons were made within subjects.
Period Title: Overall Study
STARTED 19
COMPLETED 19
NOT COMPLETED 0

Baseline Characteristics

Arm/Group Title Research Study Participation
Arm/Group Description Participants who were enrolled in the study and completed all study procedures.
Overall Participants 19
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
46.6
(7.9)
Sex: Female, Male (Count of Participants)
Female
0
0%
Male
19
100%
Race (NIH/OMB) (Count of Participants)
American Indian or Alaska Native
0
0%
Asian
0
0%
Native Hawaiian or Other Pacific Islander
0
0%
Black or African American
4
21.1%
White
13
68.4%
More than one race
2
10.5%
Unknown or Not Reported
0
0%
Region of Enrollment (participants) [Number]
United States
19
100%
Occupational Industry (Count of Participants)
Food Service
8
42.1%
Material Moving
9
47.4%
Healthcare
1
5.3%
Building and Grounds Maintenance
1
5.3%

Outcome Measures

1. Primary Outcome
Title 24-hour Heart Rate
Description We will calculate the average heart rate over each 24 hour period throughout a one week monitoring period.
Time Frame 24 hours

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Research Study Participation
Arm/Group Description Participants who were enrolled in the study and completed all study procedures.
Measure Participants 19
Workdays
83.8
(1.2)
Non-workdays
78.5
(1.4)
2. Secondary Outcome
Title 24-hour Ambulatory Systolic Blood Pressure
Description We will calculate the average systolic blood pressure over a 24-hour period on two separate days (workdays versus non-workdays).
Time Frame 24 hours

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Research Study Participation
Arm/Group Description Participants who were enrolled in the study and completed all study procedures.
Measure Participants 19
Workdays
126.0
(1.7)
Non-workdays
124.0
(1.8)
3. Secondary Outcome
Title Nocturnal Heart Rate Variability, RMSSD
Description We will calculate the average heart rate variability during each night's sleep for a total of one week. The specific HRV variable presented is root mean square successive differences (RMSSD).
Time Frame approximately 8 hours (sleep time)

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Research Study Participation
Arm/Group Description Participants who were enrolled in the study and completed all study procedures.
Measure Participants 19
workdays
34.17
(4.04)
non-workdays
35.34
(4.32)
4. Secondary Outcome
Title Physical Activity Pattern. Steps Per Day
Description This physical activity metric of steps per day was calculated as average number of steps during each day type (work versus non-workdays) throughout one week
Time Frame 1 week

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Research Study Participation
Arm/Group Description Participants who were enrolled in the study and completed all study procedures.
Measure Participants 19
Workdays
12,772
(945)
Non-workdays
7,923
(1,063)
5. Secondary Outcome
Title Nocturnal Heart Rate Variability, SDNN
Description We will calculate the average heart rate variability during each night's sleep for a total of one week. The specific HRV variable presented is standard deviation of the normal to normal RR intervals (SDNN).
Time Frame approximately 8 hours (sleep time)

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Research Study Participation
Arm/Group Description Participants who were enrolled in the study and completed all study procedures.
Measure Participants 19
workdays
39.85
(3.48)
non-workdays
42.14
(3.71)
6. Secondary Outcome
Title Nocturnal Heart Rate Variability, LF
Description We will calculate the average heart rate variability during each night's sleep for a total of one week. The specific HRV variable presented is low frequency power (LF).
Time Frame approximately 8 hours (sleep time)

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Research Study Participation
Arm/Group Description Participants who were enrolled in the study and completed all study procedures.
Measure Participants 19
workdays
6.18
(0.20)
non-workdays
6.45
(0.21)
7. Secondary Outcome
Title Nocturnal Heart Rate Variability, HF
Description We will calculate the average heart rate variability during each night's sleep for a total of one week. The specific HRV variable presented is high frequency power (HF).
Time Frame approximately 8 hours (sleep time)

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Research Study Participation
Arm/Group Description Participants who were enrolled in the study and completed all study procedures.
Measure Participants 19
workdays
5.22
(0.30)
non-workdays
5.56
(0.31)
8. Secondary Outcome
Title Physical Activity Pattern. MVPA
Description This physical activity metric of minutes of moderate to vigorous physical activity was calculated as average minutes during each day type (work versus non-workdays) throughout one week
Time Frame 1 week

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Research Study Participation
Arm/Group Description Participants who were enrolled in the study and completed all study procedures.
Measure Participants 19
Workdays
72.4
(7.2)
Non-workdays
41.5
(8.9)
9. Secondary Outcome
Title Physical Activity Pattern. LPA
Description This physical activity metric of minutes of light physical activity was calculated as average minutes during each day type (work versus non-workdays) throughout one week
Time Frame 1 week

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Research Study Participation
Arm/Group Description Participants who were enrolled in the study and completed all study procedures.
Measure Participants 19
Workdays
391.5
(19.9)
Non-workdays
285.2
(23.3)
10. Secondary Outcome
Title Physical Activity Pattern. Sedentary
Description This physical activity metric of minutes of sedentary time was calculated as average minutes during each day type (work versus non-workdays) throughout one week
Time Frame 1 week

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Research Study Participation
Arm/Group Description Participants who were enrolled in the study and completed all study procedures.
Measure Participants 19
Workdays
492.5
(18.4)
Non-workdays
629.7
(22.5)
11. Secondary Outcome
Title Physical Activity Pattern. Upright
Description This physical activity metric of minutes of upright time was calculated as average minutes during each day type (work versus non-workdays) throughout one week
Time Frame 1 week

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Research Study Participation
Arm/Group Description Participants who were enrolled in the study and completed all study procedures.
Measure Participants 19
Workdays
462.4
(18.4)
Non-workdays
325.2
(22.5)
12. Secondary Outcome
Title 24-hour Ambulatory Diastolic Blood Pressure
Description We will calculate the average diastolic blood pressure over a 24-hour period on two separate days (workdays versus non-workdays).
Time Frame 24 hours

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Research Study Participation
Arm/Group Description Participants who were enrolled in the study and completed all study procedures.
Measure Participants 19
Workdays
75.2
(1.0)
Non-workdays
72.6
(1.1)

Adverse Events

Time Frame 1 week
Adverse Event Reporting Description
Arm/Group Title Research Study Participation
Arm/Group Description Participants who were enrolled in the study and completed all study procedures.
All Cause Mortality
Research Study Participation
Affected / at Risk (%) # Events
Total 0/19 (0%)
Serious Adverse Events
Research Study Participation
Affected / at Risk (%) # Events
Total 0/19 (0%)
Other (Not Including Serious) Adverse Events
Research Study Participation
Affected / at Risk (%) # Events
Total 0/19 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Dr. Tyler Quinn
Organization Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health
Phone 412-386-4450
Email yhh7@cdc.gov
Responsible Party:
Tyler Quinn, Principle Investigator, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT04075279
Other Study ID Numbers:
  • STUDY19050097
First Posted:
Aug 30, 2019
Last Update Posted:
May 3, 2021
Last Verified:
Apr 1, 2021